BPC-157

Overview

BPC-157 is a pentadecapeptide (15 amino acids) derived from human gastric juice. It has been studied extensively in animal models for its potential tissue-protective and healing effects across multiple organ systems.

Mechanism of Action

BPC-157 appears to act through multiple pathways including upregulation of growth factor expression (EGF, VEGF), modulation of the nitric oxide system, and interaction with the dopaminergic system. It has shown effects on angiogenesis and wound healing in preclinical studies.

Research Summary

Extensive preclinical research in rodent models demonstrates accelerated healing of tendons, ligaments, muscles, and the gastrointestinal tract. Human clinical trials are limited but underway. It remains one of the most studied peptides in regenerative medicine.

Dosing Information

Reported Side Effects

• Nausea (especially oral)
• Dizziness
• Injection site irritation
• Headache

Labs to monitor before & during your BPC-157 protocol

These biomarkers are commonly tracked to assess response and safety. Run baseline labs before starting, mid-cycle labs halfway through, and post-cycle labs 1–2 weeks after the final dose.

Commonly Stacked With

Research References

• Sikiric P, et al. Journal of Physiology Paris. 1999;93(6):505-513.
• Chang CH, et al. Life Sciences. 2011;88(1-2):7-14.
• Seiwerth S, et al. Current Pharmaceutical Design. 2018;24(18):1990-2001.